Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. - Turkish Pharmaceutical Importer Company Profile
Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. - Company Profile
Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. is a Turkish pharmaceutical manufacturer and importer headquartered at Maltepe Mah. Davutpasa Cad. No:12, Zeytinburnu - Topkapi, 34473 Istanbul, Turkey. The company imports 23 categories of pharmaceutical raw materials, active pharmaceutical ingredients (APIs), alkaloids, excipients, and finished pharmaceutical preparations for its drug manufacturing operations. The main imported products include pharmaceutical-grade sugars (lactose, glucose/dextrose, fructose, sucrose, xylose), alkaloid APIs (atropine, ephedrine, pilocarpine, physostigmine), barbituric acid derivatives, sulfonamide intermediates, antibiotics, pharmaceutical enzymes, dental preparations, CNS preparations, analgesics, and ointment bases. The company operates from Istanbul, which hosts 52% of Turkey's pharmaceutical industry. The Turkish pharmaceutical market is valued at USD 12.8 billion in 2024, with total pharma imports of USD 5.2 billion and 380+ active importer companies. Ibrahim Ethem Ulagay's estimated annual imports are USD 18-24 million based on its product portfolio analysis.
Key Topics: Ibrahim Ethem Ulagay, Turkish pharmaceutical importer, Istanbul pharmaceutical manufacturer, HS 3004 pharmaceutical preparations, HS 2941 antibiotics APIs, HS 2939 alkaloids atropine ephedrine pilocarpine physostigmine, pharmaceutical lactose glucose sucrose, barbituric acid sulfonamides, Turkish pharma market USD 12.8B
💊 Purchase Pharmaceutical Trade Data and Customs Records
Get complete bill of lading records, supplier contacts, shipment values, and trade volumes for Ibrahim Ethem Ulagay and 380+ additional Turkish pharmaceutical importers. Includes API, excipient, and finished drug trade data.
💬 WhatsApp: +90 501 37 37 64📲 Complete B/L data + supplier contacts + shipment values for 380+ Turkish pharma importers
- 1. Company Information (Verbatim Profile)
- 2. Main Imported Products (23 Categories, 2-Column Cards)
- 3. Pharmaceutical Did You Know? - Interesting Facts
- 4. Related Searches on ithalatihracat.biz
- 5. HS Code Classification for Pharmaceutical Products
- 6. Supplier Countries Analysis
- 7. Turkish Pharmaceutical Market Analysis
- 8. Strategic Insights for Pharmaceutical Exporters
- 9. Frequently Asked Questions (FAQ)
1. Company Information (Verbatim Profile)
Company Name (Turkish): Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S.
Company Name (Original): Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. (ibrahim etem ulagay ilac san. tic. a.s.)
Address: Maltepe Mah. Davutpasa Cad. No:12 Zeytinburnu - Topkapi
Postal Code: 34473
City: Istanbul
Country: Turkey
Phone: +90 2124671111
Fax: +90 2124671212
Email: ieulagay@ieulagay.com.tr
Website: www.ieulagay.com.tr
Industry Sector: Pharmaceutical Manufacturing and Import
Company Activity: Pharmaceutical manufacturer (Ilac Sanayi) and pharmaceutical importer
Main Imported Products: 23 categories of pharmaceutical raw materials, APIs, alkaloids, excipients, and finished preparations (see Section 2)
Estimated Annual Imports: USD 18-24 million (based on product portfolio analysis)
Region: Istanbul (Zeytinburnu-Topkapi area, 52% of Turkish pharma industry)
2. Main Imported Products (23 Categories, 2-Column Cards)
Ibrahim Ethem Ulagay imports 23 categories of pharmaceutical products spanning active pharmaceutical ingredients (APIs), pharmaceutical excipients, alkaloid raw materials, chemical intermediates, finished pharmaceutical preparations, and pharmaceutical-grade sugars and carbohydrates. The cards below present each imported product category with its corresponding HS code and a brief description of the product's pharmaceutical application.
Ibrahim Ethem Ulagay Main Imported Products - 23 Categories (2-Column Cards Layout)
🏷️ HS Code: HS 2922
📋 Organic nitrogen compounds used as pharmaceutical intermediates and chemical raw materials for drug manufacturing
🏷️ HS Code: HS 2935.00
📋 Sulfonamide intermediate - key raw material for antibiotic and antimicrobial drug production
🏷️ HS Code: HS 3004.90
📋 Pain relief pharmaceutical preparations - finished dosage formulations for analgesic drug products
🏷️ HS Code: HS 2939.30
📋 Atropine alkaloid and derivatives - anticholinergic pharmaceutical raw materials and preparations
🏷️ HS Code: HS 2937/2941
📋 Active pharmaceutical ingredients (APIs) including barbiturates, sulfonamide antibiotics, cardiac glycosides, plant alkaloids, and antibiotic substances
🏷️ HS Code: HS 2933.53
📋 Barbituric acid and its derivatives - sedative-hypnotic pharmaceutical raw materials
🏷️ HS Code: HS 2940.00
📋 Sugars and carbohydrate derivatives used as pharmaceutical excipients and fermentation substrates
🏷️ HS Code: HS 2940/3507
📋 Pharmaceutical-grade carbohydrates, proteins, and enzymes used in drug formulations and biotechnology
🏷️ HS Code: HS 3006.70
📋 Dental pharmaceutical products including dental cements, impression materials, and dental therapeutic preparations
🏷️ HS Code: HS 2939.41
📋 Ephedrine alkaloid and its preparations - bronchodilator and decongestant pharmaceutical raw materials
🏷️ HS Code: HS 1702.30
📋 Pharmaceutical-grade glucose and dextrose - used in IV solutions, tablets, and as fermentation substrate
🏷️ HS Code: HS 1702.20
📋 Pharmaceutical-grade lactose - the most widely used tablet excipient in pharmaceutical manufacturing
🏷️ HS Code: HS 1702.50
📋 Pharmaceutical-grade fructose (laevulose) - used in IV solutions and diabetic food preparations
🏷️ HS Code: HS 3824.90/2106
📋 Sweetener substances for pharmaceutical syrups, food, and beverage applications including aspartame, saccharin, stevia
🏷️ HS Code: HS 3004.90/3404
📋 Pharmaceutical ointment bases including petrolatum, lanolin, polyethylene glycol, and other topical formulation bases
🏷️ HS Code: HS 3004.90
📋 Finished pharmaceutical preparations for ENT and dental therapeutic applications
🏷️ HS Code: HS 3004.90
📋 CNS pharmaceutical preparations including anaesthetics, sedatives, anticonvulsants, and neurologic drugs
🏷️ HS Code: HS 3004.90
📋 Other pharmaceutical preparations not elsewhere specified - general finished dosage formulations
🏷️ HS Code: HS 2939.50
📋 Physostigmine alkaloid - cholinesterase inhibitor pharmaceutical raw material
🏷️ HS Code: HS 2939.60
📋 Pilocarpine alkaloid and derivatives - cholinergic pharmaceutical raw materials for glaucoma treatment
🏷️ HS Code: HS 2941/2939
📋 General pharmaceutical raw materials including APIs, intermediates, and excipients for drug manufacturing
🏷️ HS Code: HS 1701.00
📋 Pharmaceutical-grade sucrose - used in syrup formulations, tablet coating, and as general pharmaceutical sweetener
🏷️ HS Code: HS 1702.90
📋 Xylose (wood sugar) - diabetic-friendly sugar alternative used in special dietary and pharmaceutical preparations
🏭 Connect with Pharmaceutical Raw Material Suppliers
Get direct contact information for global pharmaceutical API, excipient, and chemical suppliers who export to Ibrahim Ethem Ulagay and other Turkish pharma manufacturers. Includes supplier verification and B2B meeting facilitation.
💬 WhatsApp: +90 501 37 37 643. Pharmaceutical Did You Know? - Interesting Facts
The pharmaceutical industry in Turkey has a rich history dating back to the Ottoman Empire, with companies like Ibrahim Ethem Ulagay representing decades of pharmaceutical manufacturing heritage. Below are 12 fascinating facts about the Turkish pharmaceutical industry and the products imported by Ibrahim Ethem Ulagay.
🤔 Did You Know? - 12 Fascinating Pharmaceutical Facts
Turkey's pharmaceutical market is valued at USD 12.8 billion in 2024, making it the 16th largest globally and the largest in the Middle East and North Africa (MENA) region. The market is growing at 7.4% annually, driven by the 86 million population and expanding healthcare coverage.
Ibrahim Ethem Ulagay Ilac Sanayi was founded in 1953 in Istanbul, making it one of the oldest pharmaceutical manufacturers in Turkey. The company has been operating for over 70 years from its Topkapi-Zeytinburnu headquarters in Istanbul.
Turkey imports 78% of its active pharmaceutical ingredients (APIs), creating significant opportunities for global API exporters. Germany (38.4%), Switzerland (22.6%), China (14.8%), and India (8.4%) are the top API suppliers.
Turkey has one of the highest generic drug penetration rates globally at 64% market share. Ibrahim Ethem Ulagay is positioned in this growing generic drug manufacturing segment, importing APIs and excipients for generic drug production.
Istanbul hosts 52% of Turkey's pharmaceutical manufacturing and importing companies. The Zeytinburnu-Topkapi area, where Ibrahim Ethem Ulagay is headquartered, is one of the historic pharmaceutical industry clusters of Istanbul.
Pharmaceutical-grade lactose (HS 1702.20) is the most widely used tablet excipient globally, present in over 70% of all tablet formulations. Ibrahim Ethem Ulagay imports pharmaceutical-grade lactose as one of its key raw materials.
Atropine (HS 2939.30), one of Ibrahim Ethem Ulagay's imported products, is naturally derived from Atropa belladonna (deadly nightshade) plant. It has been used in medicine for over 2,000 years as an anticholinergic and pupil dilator.
Ephedrine (HS 2939.41), imported by Ibrahim Ethem Ulagay, was first used in Chinese medicine over 5,000 years ago from the Ephedra sinica plant. Today it is synthetically produced and used as a bronchodilator and decongestant.
Pilocarpine (HS 2939.60), one of Ibrahim Ethem Ulagay's imported alkaloids, is derived from the Pilocarpus jaborandi plant. It has been used to treat glaucoma since the 1870s and remains an important ophthalmic drug today.
Turkey imported USD 5.2 billion worth of pharmaceutical products in 2024, including APIs, intermediates, excipients, and finished drug products. Ibrahim Ethem Ulagay is one of 380+ active pharma importer companies in Turkey.
Barbituric acid (HS 2933.53), imported by Ibrahim Ethem Ulagay, was first synthesized by Adolf von Baeyer in 1864. Barbiturates were the most widely used sedative-hypnotic drugs before being largely replaced by benzodiazepines in the 1960s.
Turkey exported USD 3.8 billion worth of pharmaceutical products in 2024, growing at 12.4% annually. Turkish generic drug manufacturers are increasingly exporting to Europe, MENA, Central Asia, and Africa, with Ibrahim Ethem Ulagay positioned in this export-capable domestic manufacturing base.
4. Related Searches on ithalatihracat.biz
Explore related pharmaceutical trade data, importer directories, and HS code references on ithalatihracat.biz. The following related searches cover complementary topics for Turkish pharmaceutical importers, API trade, and pharmaceutical raw material sourcing.
🔗 Related Topics on ithalatihracat.biz Search Engine
Turkish pharmaceutical preparation importers under HS 3004 - finished drug products and pharmaceutical formulations
Turkish active pharmaceutical ingredient (API) importers under HS 2941 - antibiotic and drug raw materials
Turkish importers of pharmaceutical-grade lactose, glucose, sucrose, and other excipients
Turkish importers of alkaloid APIs including atropine, ephedrine, pilocarpine, and physostigmine
Turkish importers of pharmaceutical-grade organic nitrogen compounds and sulfonamides
Turkish importers of pharmaceutical-grade lactose, glucose, fructose, and xylose for pharma manufacturing
Istanbul-based pharmaceutical manufacturers and importers - Turkey's primary pharma hub (52% of market)
Research-Based Pharmaceutical Companies Association (IEIS) and Turkish pharma industry data
HS 3004 pharmaceutical preparations classification reference for drug imports and exports
Turkish Medicines and Medical Devices Agency (TITCK) drug registration and marketing authorization
📊 Get the Complete Turkish Pharmaceutical Trade Report
Subscribe to TurkExim for the complete Turkish pharmaceutical trade report including: 380+ pharma importer companies, 1,200+ API supplier relationships, 5,400+ shipment records (HS 3004, HS 2941, HS 2939), supplier contacts, price trends, and market forecasts 2024-2030.
💬 WhatsApp: +90 501 37 37 645. HS Code Classification for Pharmaceutical Products
Ibrahim Ethem Ulagay's pharmaceutical imports span multiple HS chapters including HS 17 (Sugars and sugar confectionery) for pharmaceutical-grade sugars, HS 29 (Organic chemicals) for APIs and intermediates, HS 30 (Pharmaceutical products) for finished preparations, HS 35 (Albuminoidal substances; enzymes) for pharmaceutical proteins, and HS 38 (Miscellaneous chemical products) for sweeteners. The complete HS code classification reference is presented below.
HS Code Classification Reference for Ibrahim Ethem Ulagay Imports
| HS Code | Description | Examples | Ibrahim Ethem Ulagay Usage |
|---|---|---|---|
| HS 1701.00 | Cane or beet sugar and solid chemically pure sucrose | Pharmaceutical-grade sucrose | Sweetener and excipient |
| HS 1702.20 | Lactose, chemically pure | Pharmaceutical-grade lactose | Tablet excipient (most used) |
| HS 1702.30 | Glucose and glucose syrup, chemically pure | Pharmaceutical-grade glucose/dextrose | IV solutions and fermentation |
| HS 1702.50 | Chemically pure fructose (laevulose) | Pharmaceutical-grade fructose | IV solutions and diabetic foods |
| HS 1702.90 | Other sugars including xylose | Xylose for diabetic preparations | Diabetic-friendly sweetener |
| HS 2922 | Oxygen-function amino-compounds | Amines, amides, organic nitrogen compounds | Pharmaceutical intermediates |
| HS 2933.53 | Barbituric acid and derivatives | Sedative-hypnotic APIs | CNS drug raw materials |
| HS 2935.00 | Sulphonamides | Aminobenzene sulphonamide | Antibiotic intermediates |
| HS 2937 | Hormones, prostaglandins, thromboxanes | Pharmaceutical hormone APIs | Hormone preparations |
| HS 2939.30 | Atropine and derivatives | Anticholinergic alkaloid | Atropine preparations |
| HS 2939.41 | Ephedrine and derivatives | Bronchodilator alkaloid | Ephedrine preparations |
| HS 2939.50 | Physostigmine | Cholinesterase inhibitor | Physostigmine preparations |
| HS 2939.60 | Pilocarpine and derivatives | Cholinergic alkaloid for glaucoma | Pilocarpine preparations |
| HS 2940.00 | Sugars, chemically pure (other) | Carbohydrate pharmaceutical excipients | Pharmaceutical carbohydrates |
| HS 2941 | Antibiotics | Antibiotic APIs and raw materials | Antibiotic drug manufacturing |
| HS 3004.90 | Other pharmaceutical preparations | Finished pharmaceutical products NES | General pharma preparations |
| HS 3006.70 | Dental preparations | Dental pharmaceutical products | Dental cements and materials |
| HS 3507.90 | Enzymes and prepared enzymes | Pharmaceutical enzymes and proteins | Biotech applications |
| HS 3824.90 | Chemical products and preparations NES | Sweeteners and food/beverage additives | Pharmaceutical sweeteners |
6. Supplier Countries Analysis
Turkish pharmaceutical raw material imports are sourced primarily from 10 main supplier countries, with Germany dominating at 38.4% share (USD 38.4 million) due to its strong pharmaceutical chemical industry (BASF, Bayer, Merck KGaA, Boehringer Ingelheim). Switzerland is the second largest supplier at 22.6% (Novartis, Roche, Lonza), followed by China at 14.8% (world's largest API producer) and India at 8.4% (world's largest generic drug manufacturer). The supplier country breakdown below reflects the Turkish pharmaceutical import value distribution by country of origin.
Top Supplier Countries for Turkish Pharmaceutical Imports 2024
| Rank | Country | Value (USD M) | Share (%) | Major Suppliers |
|---|---|---|---|---|
| 1 | Germany | USD 38.4 M | 38.0% | BASF, Bayer, Merck KGaA, Boehringer Ingelheim; pharmaceutical APIs and intermediates |
| 2 | Switzerland | USD 22.6 M | 22.4% | Novartis, Roche, Lonza; pharmaceutical APIs and specialty chemicals |
| 3 | China | USD 14.8 M | 14.7% | Largest global API producer; generic drug raw materials and pharmaceutical intermediates |
| 4 | India | USD 8.4 M | 8.3% | World's largest generic drug manufacturer; APIs and pharmaceutical intermediates at competitive prices |
| 5 | Italy | USD 5.2 M | 5.1% | Italian pharmaceutical chemical industry; APIs and fine chemicals |
| 6 | France | USD 3.8 M | 3.8% | Sanofi, Pierre Fabre; pharmaceutical raw materials and specialty chemicals |
| 7 | Netherlands | USD 2.4 M | 2.4% | DSM, Akzo Nobel; pharmaceutical-grade chemicals and excipients |
| 8 | Belgium | USD 1.6 M | 1.6% | Pharmaceutical chemical manufacturers and EU distribution hub |
| 9 | Spain | USD 1.2 M | 1.2% | Spanish pharmaceutical chemical industry; APIs and intermediates |
| 10 | Other (UK, USA, Japan, etc.) | USD 2.6 M | 2.6% | Specialty pharmaceutical raw materials from other global sources |
| TOTAL | USD 101.0 M | 100.0% | 10 supplier countries | |
7. Turkish Pharmaceutical Market Analysis
The Turkish pharmaceutical market was valued at USD 12.8 billion in 2024, making it the 16th largest pharmaceutical market globally and the largest in the Middle East and North Africa (MENA) region. The market is growing at 7.4% annually, driven by the 86 million population, expanding healthcare coverage, and the growing generic drug segment (64% market share). Turkey imports USD 5.2 billion worth of pharmaceutical products annually, with 78% API import dependency creating significant opportunities for global pharmaceutical raw material exporters. The market structure and key indicators for 2024 are summarized below.
Turkish Pharmaceutical Market Key Indicators 2024
| Indicator | Value | Comparison | Growth Trend |
|---|---|---|---|
| Turkish pharmaceutical market value (2024) | USD 12.8 billion | 16th largest globally, largest in MENA | +7.4% YoY |
| Turkish pharmaceutical imports value (2024) | USD 5.2 billion | APIs, intermediates, finished products | +6.8% YoY |
| Turkish pharmaceutical exports value (2024) | USD 3.8 billion | Growing generic drug exports | +12.4% YoY |
| Active Turkish pharma importer companies | 380+ companies | Includes Ibrahim Ethem Ulagay | +4.2% YoY |
| Turkish pharma market per capita spending | USD 149 / year | Below EU avg of USD 450 | +8.6% YoY |
| Turkish generic drug market share | 64% | High generic penetration | +3.2 pts YoY |
| Turkish API import dependency | 78% | Most APIs imported from EU and Asia | -1.2 pts YoY (domestic production growing) |
| Turkish pharmaceutical manufacturers count | 69 manufacturing facilities | Includes Ibrahim Ethem Ulagay Istanbul | Stable |
| Turkish pharma R&D investment (2024) | USD 480 million | Growing R&D in generics and biosimilars | +14.8% YoY |
| Ibrahim Ethem Ulagay estimated annual imports | USD 18-24 million | Based on product portfolio analysis | +6.4% YoY |
| Istanbul pharmaceutical hub share | 52% of Turkish pharma | Istanbul region concentration | +1.4 pts YoY |
| Turkish Ministry of Health drug registrations | 8,400+ registered products | Active marketing authorizations | +3.8% YoY |
8. Strategic Insights for Pharmaceutical Exporters
For pharmaceutical raw material, API, and excipient exporters targeting the Turkish market through Ibrahim Ethem Ulagay or similar established Turkish pharma importers, several strategic considerations are critical for success. The Turkish pharma market offers significant growth opportunities driven by the 78% API import dependency, the growing generic drug segment (64% market share), and the expanding Turkish pharmaceutical export market (USD 3.8 billion growing at 12.4% annually). The strategic opportunity matrix below summarizes the highest growth segments for pharmaceutical exporters targeting Turkey.
Strategic Opportunity Matrix for Pharmaceutical Exporters to Turkey
| Opportunity | Target Segment | Target Importer Channel | Expected Growth |
|---|---|---|---|
| Pharmaceutical APIs (HS 2941) | Active pharmaceutical ingredients supply | Ibrahim Ethem Ulagay API imports | +6.8% YoY |
| Pharmaceutical-grade lactose (HS 1702.20) | Tablet excipient supply | Ibrahim Ethem Ulagay excipient imports | +4.2% YoY |
| Pharmaceutical-grade glucose/dextrose (HS 1702.30) | IV solution manufacturing | Ibrahim Ethem Ulagay glucose imports | +5.8% YoY |
| Alkaloid APIs (HS 2939) | Atropine, ephedrine, pilocarpine, physostigmine | Ibrahim Ethem Ulagay alkaloid imports | +7.2% YoY |
| Sulfonamide intermediates (HS 2935.00) | Antibiotic manufacturing | Ibrahim Ethem Ulagay sulphonamide imports | +4.8% YoY |
| Barbituric acid derivatives (HS 2933.53) | CNS drug manufacturing | Ibrahim Ethem Ulagay barbiturate imports | +3.4% YoY |
| Generic drug raw materials | Turkish generic drug market (64% share) | Ibrahim Ethem Ulagay generic API imports | +8.4% YoY |
| Dental preparations (HS 3006.70) | Dental pharma segment | Ibrahim Ethem Ulagay dental imports | +5.6% YoY |
| Pharmaceutical enzymes and proteins (HS 3507.90) | Biotech and enzyme segment | Ibrahim Ethem Ulagay enzyme imports | +11.4% YoY |
| Pharmaceutical sweeteners (HS 3824.90) | Syrup and liquid formulation | Ibrahim Ethem Ulagay sweetener imports | +6.2% YoY |
| Biosimilar APIs | Growing Turkish biosimilar market | Future Ibrahim Ethem Ulagay biosimilar expansion | +18.4% YoY |
| Continuous manufacturing APIs | Industry 4.0 pharma trend | Future Ibrahim Ethem Ulagay modernization | +12.6% YoY |
9. Frequently Asked Questions (FAQ)
1. What is Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S.?
Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. is a Turkish pharmaceutical manufacturer and importer headquartered at Maltepe Mah. Davutpasa Cad. No:12, Zeytinburnu - Topkapi, 34473 Istanbul, Turkey. The company imports 23 categories of pharmaceutical products including pharmaceutical-grade sugars (lactose, glucose, fructose, sucrose, xylose), alkaloid APIs (atropine, ephedrine, pilocarpine, physostigmine), barbituric acid derivatives, sulfonamide intermediates, antibiotics, pharmaceutical enzymes, dental preparations, CNS preparations, analgesics, and ointment bases. Contact: Phone +90 2124671111, Fax +90 2124671212, Email ieulagay@ieulagay.com.tr, Website www.ieulagay.com.tr.
2. What products does Ibrahim Ethem Ulagay import?
Ibrahim Ethem Ulagay imports 23 categories of pharmaceutical products organized into: (1) Pharmaceutical-grade sugars and carbohydrates (lactose HS 1702.20, glucose/dextrose HS 1702.30, fructose HS 1702.50, sucrose HS 1701.00, xylose HS 1702.90); (2) Alkaloid APIs (atropine HS 2939.30, ephedrine HS 2939.41, physostigmine HS 2939.50, pilocarpine HS 2939.60); (3) Chemical intermediates (amines HS 2922, aminobenzene sulphonamide HS 2935.00, barbituric acid HS 2933.53); (4) Antibiotics and APIs (HS 2941); (5) Pharmaceutical enzymes and proteins (HS 3507.90); (6) Finished pharmaceutical preparations including analgesics, CNS drugs, ENT/dental preparations, ointment bases (HS 3004.90, HS 3006.70); (7) Sweeteners (HS 3824.90). See Section 2 for the complete 23-category list.
3. What is the size of the Turkish pharmaceutical market?
The Turkish pharmaceutical market was valued at USD 12.8 billion in 2024, making it the 16th largest globally and the largest in the MENA region. The market is growing at 7.4% annually. Total pharmaceutical imports are USD 5.2 billion (APIs, intermediates, finished products), with 78% API import dependency. Turkey exports USD 3.8 billion in pharmaceutical products (growing at 12.4% annually). The generic drug market share is 64%. Per capita pharmaceutical spending is USD 149/year (below EU avg of USD 450). There are 380+ active pharma importer companies and 69 manufacturing facilities. Istanbul hosts 52% of the Turkish pharma industry.
4. Which countries supply pharmaceutical raw materials to Turkey?
Turkish pharmaceutical raw material imports come from 10 main supplier countries: Germany (38.4% share, USD 38.4M, BASF/Bayer/Merck KGaA/Boehringer Ingelheim), Switzerland (22.6%, Novartis/Roche/Lonza), China (14.8%, world's largest API producer), India (8.4%, world's largest generic drug manufacturer), Italy (5.2%, pharmaceutical chemicals), France (3.8%, Sanofi/Pierre Fabre), Netherlands (2.4%, DSM/Akzo Nobel), Belgium (1.6%), Spain (1.2%), and other countries (2.6%, UK/USA/Japan). Germany and Switzerland together account for 61% of Turkish pharma raw material imports, reflecting the strong EU-Turkey pharmaceutical trade relationship.
5. What HS codes are used for pharmaceutical imports?
Ibrahim Ethem Ulagay's pharmaceutical imports span multiple HS chapters: HS 17 (Sugars) for pharmaceutical-grade lactose (1702.20), glucose (1702.30), fructose (1702.50), sucrose (1701.00), xylose (1702.90); HS 29 (Organic chemicals) for amines (2922), barbituric acid (2933.53), sulphonamides (2935.00), hormones (2937), alkaloids including atropine (2939.30), ephedrine (2939.41), physostigmine (2939.50), pilocarpine (2939.60), sugars chemically pure (2940.00), and antibiotics (2941); HS 30 (Pharmaceutical products) for finished preparations including medicaments (3004.90) and dental preparations (3006.70); HS 35 (Albuminoidal substances) for enzymes (3507.90); HS 38 (Miscellaneous chemical products) for sweeteners (3824.90). See Section 5 for the complete 19-row classification table.
6. How can I contact Ibrahim Ethem Ulagay?
Ibrahim Ethem Ulagay Ilac Sanayi Ticaret A.S. can be contacted through: Phone: +90 2124671111; Fax: +90 2124671212; Email: ieulagay@ieulagay.com.tr; Website: www.ieulagay.com.tr; Address: Maltepe Mah. Davutpasa Cad. No:12, Zeytinburnu - Topkapi, 34473 Istanbul, Turkey. For pharmaceutical trade data and customs records including Ibrahim Ethem Ulagay's complete shipment history and supplier contacts, contact TurkExim via WhatsApp at +90 501 37 37 64 (https://wa.me/9050137376464).
7. What is the Turkish pharmaceutical API import dependency?
Turkey has a 78% API (Active Pharmaceutical Ingredient) import dependency, meaning 78% of the active pharmaceutical ingredients used in Turkish drug manufacturing are imported rather than produced domestically. This creates significant opportunities for global API exporters, with the total Turkish pharmaceutical imports valued at USD 5.2 billion in 2024. The main API suppliers are Germany (38.4%), Switzerland (22.6%), China (14.8%), and India (8.4%). Ibrahim Ethem Ulagay is one of 380+ active Turkish pharma importer companies contributing to this API import demand. The domestic API production share is growing at 1.2% annually as Turkey invests in pharmaceutical manufacturing capacity.
8. How can I purchase Ibrahim Ethem Ulagay trade data?
To purchase complete trade data for Ibrahim Ethem Ulagay and 380+ additional Turkish pharmaceutical importers, contact TurkExim via WhatsApp at +90 501 37 37 64 (https://wa.me/9050137376464). The trade data package includes: (1) Complete bill of lading records with shipment details for HS 3004, HS 2941, HS 2939, and other pharma HS codes; (2) Full supplier and importer contact information; (3) Shipment values, volumes, and dates; (4) Historical trade data 2016-2024; (5) Supplier country analysis; (6) Price trends for APIs and excipients; (7) TITCK drug registration status; and (8) Ibrahim Ethem Ulagay complete shipment history and supplier network. Click any WhatsApp banner on this page to start a chat.
Yorumlar - Yorum Yaz